Bordetella pertussis Antibodies, IgA, IgG, and IgM by Immunoblot
Ordering Recommendation
If serology is used to assess late-stage pertussis (>4 weeks), the recommended test is Bordetella pertussis Antibodies, IgA and IgG by ELISA with Reflex to Immunoblot (2001774). CDC-recommended first-line tests for pertussis are Bordetella pertussis/parapertussis by PCR (0065080) and/or Bordetella pertussis Culture (0060117).
New York DOH Approval Status
Specimen Required
Serum separator tube.
Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.2 mL)
New York State Clients: 0.5 mL (Min: 0.25 mL)
Refrigerated.
Heat-inactivated specimens.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year
New York State Clients: Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 1 month
Methodology
Qualitative Immunoblot
Performed
Tue, Fri
Reported
1-5 days
Reference Interval
Effective February 19, 2013
Bordetella pertussis Antibodies, IgA, IgG, and IgM by Immunoblot | ||
---|---|---|
Components |
Reference Interval |
|
Bordetella pertussis Antibody, IgG by Immunoblot | ||
Bordetella pertussis Ab, IgG by Immunoblot Interp | Negative | |
B. pertussis, IgG Immunoblot PT100 | Negative | |
B. pertussis, IgG Immunoblot PT | Negative | |
B. pertussis, IgG Immunoblot FHA | Negative | |
Bordetella pertussis Antibody, IgA by Immunoblot | ||
Bordetella pertussis Ab, IgA by Immunoblot Interp | Negative | |
B. pertussis, IgA Immunoblot PT | Negative | |
B. pertussis, IgA Immunoblot FHA | Negative | |
Bordetella pertussis Antibody, IgM by Immunoblot | ||
Bordetella pertussis Ab, IgM by Immunoblot Interp | Negative | |
B. pertussis, IgM Immunoblot PT | Negative | |
B. pertussis, IgM Immunoblot FHA | Negative |
Interpretive Data
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
This assay tests for the presence of pertussis toxin (PT), pertussis toxin PT 100 (PT-100), and filamentous hemagglutinin antibody (FHA).
Hotline History
CPT Codes
86615 x3
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2004317 | B. pertussis Ab, IgA Immunoblot Interp | 50398-7 |
2004318 | B. pertussis, IgA Immunoblot PT | 74765-9 |
2004319 | B. pertussis Ab, IgG Immunoblot Interp | 50398-7 |
2004320 | B. pertussis, IgG Immunoblot FHA | 69754-0 |
2004321 | B. pertussis, IgG Immunoblot PT | 69755-7 |
2004322 | B. pertussis, IgG Immunoblot PT100 | 74766-7 |
2004323 | B. pertussis Ab, IgM Immunoblot Interp | 50398-7 |
2004324 | B. pertussis, IgM Immunoblot FHA | 43882-0 |
2004325 | B. pertussis, IgM Immunoblot PT | 69368-9 |
2004397 | B. pertussis, IgA Immunoblot FHA | 69753-2 |
Aliases
- B. pertussis Abs immunoblot
- Pertussis Antibody
- Pertussis IgA,IgG, IgM Abs Immunoblot